DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erythrocin (Erythromycin) - Electrolyte Imbalance - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Electrolyte Imbalance (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erythrocin (Erythromycin) where reactions include electrolyte imbalance. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Erythrocin side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-19

Patient: female, weighing 27.5 kg (60.5 pounds)

Reactions: Unresponsive To Stimuli, Hypercapnia, Chronic Respiratory Failure, Pulmonary Granuloma, Cardiac Disorder, Pco2 Increased, Disease Progression, Lung Abscess, COR Pulmonale, Chest Pain, Electrolyte Imbalance, Bronchiolitis, Blood Pressure Diastolic Decreased, Arrhythmia, Uterine Cancer, Blood Potassium Decreased, Ventricular Tachycardia, Respiratory Arrest, Depressed Level of Consciousness, Arteriosclerosis Coronary Artery, Cardiac Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Erythrocin
    Dosage: 600 mg, (200 mg, 3 in 1 d) oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 1992-01-01
    End date: 2006-06-29

Disopyramide
    Dosage: 300 mg, (100 mg, 3 in 1 d), oral
    Administration route: Oral
    Indication: Supraventricular Tachycardia
    End date: 2006-10-10

Clarithromycin
    Dosage: 200 mg, 600 mg (200 mg, 3 in 1 d) oral (400 mg (200 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 2006-06-30
    End date: 2006-09-18

Clarithromycin
    Dosage: 200 mg, 600 mg (200 mg, 3 in 1 d) oral (400 mg (200 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 2006-09-19
    End date: 2006-10-16

Acardi (Acardi) (Not Specified)
    Dosage: 5 mg, 5 mg (2.5 mg 2 in 1 d), oral
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2006-10-16

Other drugs received by patient: Theophylline; Furosemide; Ursodiol; Zolpidem Tartrate; Rabeprazole Sodium; Radiotherapy; Tiotropium Bromide Monohydrate; Isosorbide Dinitrate



Possible Erythrocin side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-13

Patient: female, weighing 27.5 kg (60.5 pounds)

Reactions: Arrhythmia, Uterine Cancer, Blood Potassium Decreased, Respiratory Failure, Ventricular Tachycardia, Chest Pain, COR Pulmonale, Respiratory Arrest, Depressed Level of Consciousness, Electrolyte Imbalance, Obstructive Airways Disorder

Adverse event resulted in: death

Drug(s) suspected as cause:
Clarithromycin
    Dosage: (200 mg (200 mg, 1 in 1 d) oral), (800 mg, 800 g (400 mg , 2 in 1 d), oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 2006-06-30
    End date: 2006-09-18

Clarithromycin
    Dosage: (200 mg (200 mg, 1 in 1 d) oral), (800 mg, 800 g (400 mg , 2 in 1 d), oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 2006-09-19
    End date: 2006-10-16

Rythmodan / 00271801 / (Rythmodan) (Not Specified)
    Dosage: (300 mg, 300 mg (100 mg, 3 in 1 d) oral)
    Administration route: Oral
    Indication: Supraventricular Tachycardia
    End date: 2006-10-16

Acardi (Acardi) (Not Specified)
    Dosage: (5 mg, 5 mg ( 2.5 mg, 2 in 1 d) oral)
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2006-10-16

Erythrocin
    Dosage: (600 mg, 600 mg (200 mg, 3 in 1 d), oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 1992-01-01
    End date: 2006-06-29

Other drugs received by patient: Zolpidem Tartrate; Rabeprazole Sodium; Furosemide; Isosorbide Dinitrate; Radiotherapy; Theophylline; Ursodiol; Tiotropium Bromid Monohydrate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017